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The high-molecular-mass form of valyl-tRNA synthetase is associated with the first elongation factor activity. It includes 
two polypeptides of about 50 kDa and two others of 40 and 30 kDa, identified as c(, 8, y and 6 subunits of eEF-IH. 
The complex of valyl-tRNA synthetase with eEF-IH is suggested to be a novel form of the first elongation factor. 
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1. INTRODUCTION 
One of the characteristic features of eukaryotic 
aminoacyl-tRNA synthetases is their ability to 
form high-molecular-mass complexes. The com- 
plex of nine aminoacyl-tRNA synthetases is now 
well characterised [l] . Valyl-tRNA synthetase is 
the only aminoacyl-tRNA synthetase, which exists 
in a high-molecular-mass form different from this 
complex [l-3]. Recently we succeeded in purifying 
the valyl-tRNA synthetase complex from rabbit 
liver [4]. This complex consists of polypeptides 
with molecular masses of 130, 50, 40 and 30 kDa 
and has a molecular mass of about 800 kDa. A 
complex with the same polypeptide composition 
was also isolated from rabbit liver by Waller et al. 
[5] and several other mammalian sources in our 
laboratory. The 130 kDa polypeptide was iden- 
tified as valyl-tRNA synthetase. In this work we 
have identified the low-molecular-mass polypep- 
tides of the complex as subunits of the heavy form 
of the first elongation factor (eEF-1H). 
2. MATERIALS AND METHODS 
Preparations of eEF-1 and eEF-2 were the kind gift of A.G. 
Correspondence address: A.D. Wolfson, A.N. Bakh Institute 
of Biochemistry, Leninsky pr. 33, Moscow 117071, USSR 
Ryasanov (Institute of Protein Research, Puschino). 80 S 
ribosomes from rabbit reticulocytes were isolated by a conven- 
tional procedure [6]. 
The valyl-tRNA synthetase complex was purified by gel 
filtration on Sepharose CL-6B and chromatography on Mono 
S and Mono Q columns (Pharmacia) as described previously 
[4]. The activity of valyl-tRNA synthetase was determined as 
described in 171. 
EF-1 activity was assayed with the poly(U)-dependent 
translational system in 50~1 of a mixture which contained 
20 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 100 mM KCI, 2 mM 
DTT, 1.2 mM GTP, 0.1 mg/ml poly(U), 10 pmol ]%]Phe- 
tRNA, 0.2 A260 units of ribosomes and 1 pg of EF-2. 
Analytical gel filtration was performed on a Superose 6 HR 
lo/30 column (Pharmacia) in 25 mM potassium phosphate (pH 
7.6), 1 mM MgClt, 300 mM KCl, 2 mM ,&mercaptoethanol, 
10% glycerol. The flow rate was 0.5 ml/min and the sample 
volume 200 pl. 
SDS-gel electrophoresis and two-dimensional gel elec- 
trophoresis were performed on minigels with PhastSystem 
(Pharmacia) according to Pharmacia recommendations [8,9]. 
Gels were stained with silver according to [lo]. 
3. RESULTS AND DISCUSSION 
Apart from the 130 kDa polypeptide identified 
earlier as valyl-tRNA synthetase, the complex con- 
tains polypeptides of 50, 40 and 30 kDa according 
to SDS electrophoresis. Since the SDS- 
electrophoresis pattern of the complex closely 
resembled that of eEF-1H (fig.l), we have sug- 
gested that the valyl-tRNA synthetase forms a 
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Fig. 1. SDS gel electrophoresis on PhastGradient Gel 10-15. (A) 
eEF-1H from rabbit reticulocytes, (B) preparation of rabbit 
liver valyl-tRNA synthetase complex. Arrowheads indicate the 
position of molecular mass markers. 
complex with eEF-1H. In order to prove this 
hypothesis several experiments were carried out. 
The eEF-1 activity of the purified complex was 
assayed in the poly(U)-dependent translational 
system without eEF-1. The activity of the valyl- 
tRNA synthetase complex was approximately the 
i 
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Fig.2. Stimulation of polyphenylalanine synthesis in poly(U)- 
dependent translational system. eEF-1H (0); valyl-tRNA 
synthetase complex (0). 
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Fig.3. Gel filtration of the purified valyl-tRNA synthetase 
complex. 
same as the conventional eEF-1H preparation 
(fig.2). The activities of eEF-1 and valyl-tRNA 
synthetase coelute upon gel 
A 
filtration of the 
Fig.4. Two-dimensional gel electrophoresis of valyl-tRNA 
synthetase complex (a) and of eEF-1H (b) from rabbit 
reticulocytes. 
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purified complex on Superose 6 (fig.3). The coelu- 
tion of both activities was also observed during the 
isolation procedure (not shown). The valyl-tRNA 
synthetase complex was analysed by two- 
dimensional gel electrophoresis for the identifica- 
tion of its polypeptides as subunits of eEF-1H 
(fig.4). Two polypeptides of about 50 kDa and p1 
values of about 9.0 and 5.0 are present in the com- 
plex (fig.4a). The comparison of the two- 
dimensional electrophoresis data for the complex 
and eEF-1H shows that they are practically iden- 
tical (fig.4). All the subunits of eEF-1H (a, fi, y 
and 6 [l 11) are present in the complex. The spot 
corresponding to valyl-tRNA synthetase was not 
observed on two-dimensional gels probably due to 
the high proteolytic lability of this enzyme. 
Since all valyl-tRNA synthetase in the extracts of 
various eukaryotic cells exists exclusively in high- 
molecular-mass form ([2-41 and unpublished) and 
is tightly associated with the subunits of eEF-lH, 
the high-molecular-mass complex is probably a 
special form of EF-1, which exists in the extracts as 
well as 400 kDa eEF-1H and 50 kDa eEF-1 L. Fur- 
ther studies will provide understanding of the func- 
tion of this particular form of elongation factor. 
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